KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 24 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $3,956,000 | -17.0% | 2,286,783 | -25.6% | 0.14% | -18.4% |
Q3 2014 | $4,766,000 | -25.0% | 3,074,972 | +10.3% | 0.17% | -32.0% |
Q2 2014 | $6,354,000 | -15.9% | 2,786,783 | 0.0% | 0.26% | -16.9% |
Q1 2014 | $7,552,000 | – | 2,786,783 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opus Point Partners Management, LLC | 746,467 | $358,000 | 0.28% |
HARBOURVEST PARTNERS LLC | 57,604 | $28,000 | 0.01% |
PRIMECAP MANAGEMENT CO/CA/ | 4,327,600 | $2,077,000 | 0.00% |
Renaissance Technologies | 564,673 | $271,000 | 0.00% |
VALLEY WEALTH MANAGERS, INC. | 15,861 | $8,000 | 0.00% |
CITIGROUP INC | 2,745 | $1,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 14,456 | $7,000 | 0.00% |
BLAIR WILLIAM & CO/IL | 53,635 | $25,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 86,700 | $42,000 | 0.00% |
Tower Research Capital LLC (TRC) | 3,055 | $1,000 | 0.00% |